Market Cap

Abliva AB Market Capitalization:

kr264.1 Million

SEK as of Jan. 1, 2024

US$26.2 Million

business Abliva AB Company Profile

Abliva AB Main Stock Listing

OMX: ABLI

Market Capitalization History of Abliva AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Abliva AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr264.1 M -39.29%
Jan. 1, 2023 kr435.0 M -36.20%
Jan. 1, 2022 kr681.8 M -29.93%
Jan. 1, 2021 kr973.0 M -38.22%
Jan. 1, 2020 kr1.57 B -13.70%
Jan. 1, 2019 kr1.82 B -47.94%
Jan. 1, 2018 kr3.51 B -29.26%
Jan. 1, 2017 kr4.96 B -50.52%
Jan. 1, 2016 kr10.02 B -82.93%
Jan. 1, 2015 kr58.69 B 150.00%
Jan. 1, 2014 kr23.48 B 5.09%
Jan. 1, 2013 kr22.34 B -4.71%
Jan. 1, 2012 kr23.44 B -11.27%
Jan. 1, 2011 kr26.42 B 36.37%
Jan. 1, 2010 kr19.37 B 205.41%
Jan. 1, 2009 kr6.34 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Abliva AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Abliva AB has the following listings and related stock indices.


Stock: OMX: ABLI

Stock: FSX: NTP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.